Ken has 40 years’ experience of the life sciences sector accumulated through working in the pharmaceutical industry in sales and marketing roles, in investment research of the sector and related corporate finance, and as a member of the management group at PA Consulting Group. At PA his activities emphasised business strategy, new product development and commercialisation, business performance improvement and organisational development. During his time at PA, Ken worked with many of the companies in the sector, including Big Pharma, SMEs / Specialists and start-ups.
Since retiring from PA in late 2013, Ken has worked independently as a consultant, and collaborated with several providers of specialist services to the life sciences sector.
In early 2015 Ken joined the board of Cytomos Ltd., a young company developing a novel approach to biological cell analysis, where his understanding of the market, product development experience and management insights have contributed to Cytomos’ progress. Ken joined the board of MGB Biopharma as Chairman in July 2016 where his experience in drug development, of ant-infectives in particular, and of business management, will provide an assist to the executive team and board.